Herbert Loong: A pleasure to collaborate with Dr. Fernando Lopez-Rios and Dr. Alicia Morgans
shared a post by on LinkedIn:
“A pleasure to have been able to collaborate with Dr. Fernando Lopez-Rios and Dr. Alicia Morgans on sharing our experiences and insights on the importance of molecular testing in lung and prostate cancers.
Check out the introductory video here.”
Quoting the post by :
“Three renowned experts share their knowledge on the challenges and considerations of biomarker testing for lung and prostate cancer.
Watch the full video to hear about:
> The journey from testing to treatment
> Pre-analytical barriers
> A range of assays available
> Real clinical cases
This educational programme is supported by an Independent Medical Education Grant from AstraZeneca and Amoy Diagnostics.”
Source:
Dr. Herbert H. F. Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.
Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.